FDA Inspection 1257425 - Dilawar Ajani, M.D., P.I. - December 16, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Dilawar Ajani, M.D., P.I., with an inspection on December 16, 2024, issued by the Dallas District Office, covering human drugs.

Company: Dilawar Ajani, M.D., P.I.
Inspection Date: December 16, 2024
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · 849c27b3-4f71-42d7-99de-ca8df74f204d